Quote | QSAM Biosciences Inc (OTCMKTS:QSAMD)
Last: | $7 |
---|---|
Change Percent: | 7.69% |
Open: | $6.5 |
Close: | $7 |
High: | $7.11 |
Low: | $6.5 |
Volume: | 2,563 |
Last Trade Date Time: | 04/06/2022 04:53:25 pm |
News | QSAM Biosciences Inc (OTCMKTS:QSAMD)
New research has identified a molecule that is involved in both cardiovascular disease and cancer metastasis. For cancer to become malignant, cells in tumors undergo various transformations that involve interactions between the tumor and an individual’s immune system. While most o...
QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical desi...
Message Board Posts | QSAM Biosciences Inc (OTCMKTS:QSAMD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
QSAM Biosciences Inc Company Name:
QSAMD Stock Symbol:
OTCMKTS Market:
QSAM Biosciences Inc Website:
New research has identified a molecule that is involved in both cardiovascular disease and cancer metastasis. For cancer to become malignant, cells in tumors undergo various transformations that involve interactions between the tumor and an individual’s immune system. While most o...
QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical desi...
QSAM Biosciences (OTCQB: QSAM) , a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment ...